CHRISTOPHER LOVELL: Open Payments
NPI 1861808230 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$23,532 in 171 payments from 18 companies in 2025. Trend: 2023 $12,641 · 2024 $15,469 · 2025 $23,532
Speaker / faculty: $15,380Food & beverage: $4,366Travel & lodging: $3,381Consulting: $405
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 33 | $9,032 |
| ABBVIE INC. | 58 | $7,465 |
| Gilead Sciences, Inc. | 32 | $5,912 |
| Novo Nordisk Inc | 5 | $201 |
| Ipsen Biopharmaceuticals, Inc | 8 | $199 |
| Intercept Pharmaceuticals, Inc. | 4 | $180 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $107 |
| Phathom Pharmaceuticals, Inc. | 7 | $72 |
| Janssen Biotech, Inc. | 3 | $55 |
| GENZYME CORPORATION | 2 | $54 |
Products named: REZDIFFRA, MAVYRET, Epclusa, RINVOQ, Wegovy, IQIRVO, CREON, OCALIVA.
Industry payments across AL — which companies pay providers there.
